menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.
Visit Cencora

Insights

Perspective, tips, and resources for moving health forward

abstract-brand-colors-texture-2
All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

A tsunami of regulations will require biopharma to look to the high ground of knowledgeable partners

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2024

Manufacturers

Understanding how to energize, extend and capitalize the lifespan of mature drugs

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2024
business man with healthcare worker

Manufacturers

Collaborative partnerships key to clearing the path for new biopharma products

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2024
MeetingConfRoomGroupLarge11160020

Manufacturers

Pharmacy Network Strategies

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2024
pharmacy

Manufacturers

Q&A – How the tendency towards decentralized supply chains has changed in CGT

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2023
Decentralized clinical trials for CGTs

Manufacturers

Changing Channels

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2023
Fridgeration distribution center

Manufacturers

Post-launch checklist: What to look for in a commercialization partner

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2023
Post-launch checklist

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2023
Amerisourcebergen representatives at Asembia

Pharmacies

3 ways your distributor can help you prepare for DSCSA compliance

AB-TB-Sq-Block
AmerisourceBergen
April 2023
People

Manufacturers

The essential guide to drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
abstract-brand-colors-texture

Pharmacies

DSCSA: Are you ready for November 2024?

AB-TB-Sq-Block
Matt Sample
AmerisourceBergen
February 2023
Dist_Drug_A-Frame_Bottles_016

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Cell and gene therapy commercialization

Manufacturers

What to consider when building a channel strategy for a rare disease product

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2022
Channel strategy for a rare disease product

Manufacturers

Nine questions about rare and orphan drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2022
GettyImages-1251485261_sRGB_JPG

Manufacturers

Working with government entities to advance access, affordability, and supply chain stability

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2021
health policy flag stethoscope

Manufacturers

Webinar: Rethink your commercialization strategy

Glen Martin headshot
Glen Martin; Donna Gilbert; Nancy Hoak
AmerisourceBergen
September 2021
Manufacturer commercialization Services

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
optimal cell and gene therapy supply chain and tracking outcomes

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Inverted color AmerisourceBergen icon
Innomar Strategies
June 2021

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Commercializing rare and orphan disease products

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
AB new brand magenta texture

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Strategic partnerships for unlocking product potential ebook

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2021
Considerations for the commercialization of cell and gene therapies

Manufacturers

How to make the most of integrated commercialization solutions

Glen Martin headshot
Glen Martin
AmerisourceBergen
March 2021
AmerisourceBergen manufacturer commercialization strategies

Manufacturers

Ebook: Virtual drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
November 2020
coronavirus_stock

Manufacturers

The road to a COVID-19 treatment launch

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2020
COVID_masks_texture

Manufacturers

Five growth drivers for the consumer healthcare products market

J Donati headshot
Jessica Donati
Strategic Global Sourcing at AmerisourceBergen
October 2020
consumer scanning products on smartphone in store

Manufacturers

Infographic: navigating health policy

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2020
health policy flag stethoscope

Manufacturers

How the Pharma Supply Chain is Responding to COVID-19

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2020
COVID-19_masks-handsanitizer

Manufacturers

Preparing for DSCSA Interoperability

AB-TB-Sq-Block
Matt Sample
AmerisourceBergen
May 2019

Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2018

How manufacturers can benefit from provider-led care coordination to improve patient outcomes.

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2018

How is manufacturer thinking around channel strategy changing for oral oncolytics?

Manufacturers

Improving Customer Experience and Driving Long-Term Value for Manufacturers

Rich_Tremonte_Seamless_1_2016
Rich Tremonte
AmerisourceBergen
August 2017

Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.